Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

The ‘4S’ Pathway was designed to guide shifting needs in older adults with diabetes who are struggling with diabetes ...

Dr. Jean-Francois Yale, MD, CSPQ, FRCPC, Endocrinologist, discusses how to avoid Hypoglycemia in Type 1 & 2 Diabetes.